<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04823780</url>
  </required_header>
  <id_info>
    <org_study_id>20200901-Qilu</org_study_id>
    <nct_id>NCT04823780</nct_id>
  </id_info>
  <brief_title>The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis</brief_title>
  <official_title>Investigation of the Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis:An Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Qilu Hospital of Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Qilu Hospital of Shandong University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to evaluate the safety of early enteral nutrition on endoscopic&#xD;
      therapy of esophagogastric varices in Liver Cirrhosis ,and to assess the impact of different&#xD;
      eating times on patients, so as to determine the best time for patients to obtain nutrition&#xD;
      after surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For patients with gastroesophageal varices in Liver Cirrhosis,, there is no clear guideline&#xD;
      and consensus on when to start eating after endoscopic treatment. In 2015, a randomized&#xD;
      controlled study in Taiwan of China confirmed that compared with liquid diet given 48 h after&#xD;
      endoscopic treatment, liquid diet given 4 h and started enteral nutrition would not increase&#xD;
      the risk of rebleeding, and could improve the nutritional status of patients. However, some&#xD;
      patients after endoscopic treatment would suffer from post-sternal pain, abdominal pain,&#xD;
      nausea, vomiting and other discomforts, affecting appetite and delay the diet time. Based on&#xD;
      the above research background, we observed and evaluated the safety and effectiveness of&#xD;
      early enteral nutrition in patients with cirrhotic esophageal and gastric varices after&#xD;
      endoscopic treatment, and analyzed the influencing factors of enteral nutrition in patients&#xD;
      with cirrhotic esophageal and gastric varices after endoscopic treatment, so as to further&#xD;
      clarify the optimal time for patients to eat after endoscopic treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>rebleeding</measure>
    <time_frame>2 to 30days</time_frame>
    <description>the rate of rebleeding after endoscopic therapy</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Liver Cirrhosis</condition>
  <condition>Esophageal and Gastric Varices</condition>
  <arm_group>
    <arm_group_label>early enteral nutrition support group</arm_group_label>
    <description>Nutrient solution is provided through oral nutrient solution within 4-48 hours after endoscopic treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>parenteral Nutrition Group</arm_group_label>
    <description>Intravenous nutrition is provided within 48 hours after endoscopic treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>nutrient solution</intervention_name>
    <description>For the patients with esophageal and gastric varices after endoscopic treatmentï¼Œstart taking the nutrient solution at the fourth hour.</description>
    <arm_group_label>early enteral nutrition support group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with cirrhosis of gastroesophageal varices undergoing endoscopic&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with cirrhosis of gastroesophageal varices undergoing endoscopic therapy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Endoscopic treatment of uncontrollable bleeding&#xD;
&#xD;
          -  Accompanied with other endoscopic treatments that need to be fasting&#xD;
&#xD;
          -  With obvious hepatic encephalopathy and liver failure&#xD;
&#xD;
          -  Did not sign the informed consent form and refused to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gao Yanjing, PhD.MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Qilu Hospital , Shandong University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Qilu Hospital , Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>February 4, 2021</study_first_submitted>
  <study_first_submitted_qc>March 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>March 28, 2021</last_update_submitted>
  <last_update_submitted_qc>March 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Early enteral nutrition</keyword>
  <keyword>Esophageal and Gastric Varices</keyword>
  <keyword>Rebleeding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Esophageal and Gastric Varices</mesh_term>
    <mesh_term>Varicose Veins</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

